XML 29 R21.htm IDEA: XBRL DOCUMENT v3.19.2

Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2019

Financial Instruments

Schedule of Contingent consideration

		Diabetes
		Alliance		Other		Total		Total
		2019		2019		2019		2018
		$m		$m		$m		$m
At 1 January		3,983		1,123		5,106		5,534
Settlements		(225)		(143)		(368)		(151)
Revaluations		-		-		-		38
Discount unwind		144		35		179		208
At 30 June		3,902		1,015		4,917		5,629

X

- Definition

The disclosure of contingent liabilities in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2018-01-01
-Paragraph B64
-Subparagraph j
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2018-03-01&anchor=para_B64_j&doctype=Appendix&seq=2
-URIDate 2018-03-16

+ Details

Name:	ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfFinancialInstrumentsAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration